Lipid-lowering and anti-aggregant Allicor activity in patients with moderate hypercholesterolemia
Aim. To assess long-term (6 months) Allicor therapy effects on lipid profile, lipid peroxidation (LP), and functional platelet (PL) activity in patients with moderate hypercholesterolemia (HCH). Material and methods. The study included 56 patients with clinically manifested atherosclerosis and 56 pa...
Main Authors: | N. I. Gromnatsky, Zh. E. Sereditskaya, N. V. Lazareva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1356 |
Similar Items
-
Aluminum induces lipid peroxidation and aggregation of human blood platelets
by: T.J.C. Neiva, et al.
Published: (1997-05-01) -
Evaluation of Dyslipidemia, Lipid Ratios and Atherogenic Index as Cardiovascular Risk Factors in Overt and Subclinical Hypothyroid Patients
by: Shivakrishna G, et al.
Published: (2013-07-01) -
The characteristic features of the relationship of thyroid, hemostasis and lipid peroxidation
by: Ольга Федорівна Мисник
Published: (2015-11-01) -
Dislipoproteinemia y diabetes mellitus. Dyslipoprotein disease and diabetes mellitus.
by: Manuel Emiliano Licea Puig, et al.
Published: (2010-01-01) -
Attenuation of lipid peroxidation and atherogenic factors in diabetic patients treated with gliclazide and metformin
by: Sujan Banik, et al.
Published: (2018-01-01)